Therapeutic efficacy of aldoxorubicin in an intracranial xenograft mouse model of human glioblastoma.

Neoplasia · 2014 · PMC4212249 · PMID 25379024

Europe PMC DOI

hedged sentence

0.0002

closest p · 0.0× alpha

0.0002

boldest claim

The sentences

highly significantP = 0.0002actually significant

The results shown in Figure 3 , demonstrate a highly significant improvement in the survival time in Aldoxo-treated mice as compared with control or Doxo-treated mice ( P = 0.0002 for each comparison).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.